Bumper Offer - Urjas oil Just @ Rs. 1
Sefjim-Ox is an allopathic medicine The correct dosage of Sefjim-Ox depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Sefjim-Ox is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Sefjim-Ox is used -
Severe
Moderate
Mild
Is the use of Sefjim-Ox safe for pregnant women?
Sefjim-Ox is safe for pregnant women.
Is the use of Sefjim-Ox safe during breastfeeding?
Sefjim-Ox does not show any harmful effects in lactating women.
What is the effect of Sefjim-Ox on the Kidneys?
Sefjim-Ox rarely affects the kidneys.
What is the effect of Sefjim-Ox on the Liver?
Sefjim-Ox does not damage the liver.
What is the effect of Sefjim-Ox on the Heart?
Sefjim-Ox is completely safe for the heart.
Sefjim-Ox should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Sefjim-Ox unless your doctor advises you to do so -
Is this Sefjim-Ox habit forming or addictive?
Sefjim-Ox does not cause addiction.
Interaction between Food and Sefjim-Ox
Taking Sefjim-Ox with food does not cause any problems.
Interaction between Alcohol and Sefjim-Ox
No research has been done on this till date. Therefore, it is not known what the effect of taking Sefjim-Ox with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
